156 related articles for article (PubMed ID: 18444913)
1. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients.
Stern M; Elsässer H; Hönger G; Steiger J; Schaub S; Hess C
Am J Transplant; 2008 Jun; 8(6):1312-7. PubMed ID: 18444913
[TBL] [Abstract][Full Text] [Related]
2. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.
Farzamikia N; Hejazian SM; Haghi M; Hejazian SS; Zununi Vahed S; Ardalan M
Immunogenetics; 2022 Apr; 74(2):207-212. PubMed ID: 35091752
[TBL] [Abstract][Full Text] [Related]
4. Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.
Gallez-Hawkins GM; Franck AE; Li X; Thao L; Oki A; Gendzekhadze K; Dagis A; Palmer J; Nakamura R; Forman SJ; Senitzer D; Zaia JA
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1662-72. PubMed ID: 21596150
[TBL] [Abstract][Full Text] [Related]
5. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
[TBL] [Abstract][Full Text] [Related]
6. The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.
Brochot E; Desoutter J; Presne C; De Araujo I; Flahaut G; Castelain S; Westeel PF; Choukroun G; Guillaume N
Transpl Int; 2016 Nov; 29(11):1168-1175. PubMed ID: 27516136
[TBL] [Abstract][Full Text] [Related]
7. Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients.
Kovacevic Vojtusek I; Burek Kamenaric M; Ivkovic V; Bulimbasic S; Marekovic I; Coric M; Bosnjak Z; Grubic Z; Zunec R
HLA; 2019 Dec; 94 Suppl 2():4-10. PubMed ID: 31361395
[TBL] [Abstract][Full Text] [Related]
8. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.
Gonzalez A; Schmitter K; Hirsch HH; Garzoni C; van Delden C; Boggian K; Mueller NJ; Berger C; Villard J; Manuel O; Meylan P; Stern M; Hess C;
Genes Immun; 2014 Oct; 15(7):495-9. PubMed ID: 25008861
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
10. Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
Schmied L; Terszowski G; Gonzalez A; Schmitter K; Hirsch HH; Garzoni C; van Delden C; Boggian K; Mueller NJ; Berger C; Villard J; Manuel O; Meylan P; Hess C; Stern M;
Transplantation; 2015 Dec; 99(12):2651-5. PubMed ID: 26050016
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.
Hadaya K; de Rham C; Bandelier C; Bandelier C; Ferrari-Lacraz S; Jendly S; Berney T; Buhler L; Kaiser L; Seebach JD; Tiercy JM; Martin PY; Villard J
Am J Transplant; 2008 Dec; 8(12):2674-83. PubMed ID: 19032228
[TBL] [Abstract][Full Text] [Related]
12. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation.
Stern M; Hadaya K; Hönger G; Martin PY; Steiger J; Hess C; Villard J
Am J Transplant; 2011 Jun; 11(6):1302-7. PubMed ID: 21486386
[TBL] [Abstract][Full Text] [Related]
13. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
[TBL] [Abstract][Full Text] [Related]
14. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation.
Cook M; Briggs D; Craddock C; Mahendra P; Milligan D; Fegan C; Darbyshire P; Lawson S; Boxall E; Moss P
Blood; 2006 Feb; 107(3):1230-2. PubMed ID: 16239436
[TBL] [Abstract][Full Text] [Related]
15. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
Chen C; Busson M; Rocha V; Appert ML; Lepage V; Dulphy N; Haas P; Socié G; Toubert A; Charron D; Loiseau P
Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
[TBL] [Abstract][Full Text] [Related]
16. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
[TBL] [Abstract][Full Text] [Related]
17. Killer-cell immunoglobulin-like receptors and cytomegalovirus reactivation during late pregnancy.
Alvarado-Hernández DL; Benítez-Sánchez A; Rodríguez-Cuevas JS; Rosales-Saavedra T; Guerra-Palomares SE; Comas-García A; Noyola DE; García-Sepúlveda CA
Int J Immunogenet; 2016 Aug; 43(4):189-99. PubMed ID: 27277336
[TBL] [Abstract][Full Text] [Related]
18. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
19. Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska-Jakubowicz A; Gozdowska J; Ciszek M; Pazik J; Ostaszewska A; Kosieradzki M; Nowak J; Durlik M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696053
[TBL] [Abstract][Full Text] [Related]
20. Impact of antimetabolite discontinuation following cytomegalovirus or BK polyoma virus infection in kidney transplant recipients.
Dubrawka CA; Progar KJ; January SE; Hagopian JC; Nesselhauf NM; Malone AF
Transpl Infect Dis; 2022 Dec; 24(6):e13931. PubMed ID: 35980197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
